| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Intestinal Disease Research Programme,*McMaster University, Hamilton, Ontario, Canada; the Hospital for Sick Children,University of Toronto, Toronto, Ontario, Canada; and the Department of Surgery,University Hospital, Linköping, Sweden
 |
Abstract |
|---|
 Top Abstract Materials and MethodsResultsDiscussionReferences |
|---|
|
Materials and Methods |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
Consent was obtained from patients with colon cancer (as controls) or Crohn’s disease and sections of mildly inflamed ileum were processed for transmission electron microscopy (EM).15 Sections on coded slides were examined for evidence of epithelial structural abnormalities and the average mitochondrial area was calculated from 60 mitochondria in two to four sections from each tissue.16
Rodent Studies
A 2-cm mid-abdominal incision was made in anesthetized male Sprague-Dawley rats (Charles River Laboratories, St. Constant, Quebec, Canada) and dinitrophenol [DNP: 0.5 ml of 3 mmol/L in 5% dimethyl sulfoxide/phosphate-buffered saline (PBS)17 (Sigma Chemical Co., St. Louis, MO)] was injected into the ileal lumen, 10 cm proximal to the ileal-cecal junction. The incision was closed and a 10-cm segment of terminal ileum was removed 6 hours or 24 hours later. Portions of tissue were fixed for EM or formalin-fixed for the enumeration of immune cells on hematoxylin and eosin (H&E)-stained sections (cells in 10 microscopic fields were counted from each well-oriented section).16 Two-cm portions were mounted in Ussing chambers and, under voltage clamped conditions, ion conductance was calculated (indicative of barrier to passive ion flux) and the mucosal-to-serosal flux of horseradish peroxidase (HRP) (type IV, Sigma Chemical Co.) determined following a published protocol.15 Age- and time-matched control rats were injected with 0.5 ml of 5% dimethyl sulfoxide/PBS only. Additional ileal pieces were excised, rinsed in PBS (three times), treated with gentamicin (200 µg/ml), extensively washed, and then homogenized. Homogenates were grown on blood agar for 24 hours and colony-forming units (cfu) enumerated by serial dilution counts and normalized against the original tissue weight. These studies were performed in compliance with institutional and governmental regulations relating to the use of animals in research.
In Vitro Cell Culture Studies
Cell Lines, Bacteria, and Reagents
The human colon-derived crypt-like T84 and HT-29 epithelial cell lines were maintained and cultured as previously described.18
E. coli strains HB10119
and C2520
were cultured in Luria Bertani (LB) broth. Pharmacological inhibitors were purchased from Calbiochem (San Diego, CA): U0126 (25 µmol/L) and PD98059 (50 µmol/L) block the ERK 1/2 mitogen-activated protein kinase (MAPK) pathway; SB203580 (10 µmol/L) inhibits p38 MAPK activity;21
pyrrolidinedithiocarbamate (50 µmol/L) inhibits nuclear factor (NF)-
B activation; and SN50 (20 µmol/L) blocks nuclear import and inhibits NF-B activation. Indomethacin (general cyclooxygenase inhibitor and can disrupt electron transfer) and the inhibitors of myosin light chain kinase (MLCK) (ie, ML-7, 20 µmol/L)22
and phosphatidylinositol 3'-kinase (PI-3K) (ie, LY294002, 20 µmol/L)23
activity were purchased from Sigma Chemical Co.
Epithelial cells were grown to confluence (ie, T84 cells, TER 
1000 
· cm2; HT-29 cells, TER >250 · cm2) on 0.4- or 3-µm pore-size filter supports (Costar Inc., Cambridge, MA) or until 
80% confluence (determined by phase contrast microscopy) on 12-well culture plates. DNP (1.0 or 0.1 mmol/L) and E. coli strains (106 cfu unless stated otherwise) were added simultaneously to the apical side of filter-grown monolayers. Controls: 1) time-matched naïve monolayers, 2) DNP only, and 3) E. coli HB101 (or C25) only. In some experiments 10 µmol/L indomethacin was used instead of DNP.24
In some experiments an 18-hour incubation with enteropathogenic E. coli (EPEC, 106 cfu) was used as a positive control for bacterial disruption of epithelial barrier function.19
Epithelial Cell Mitochondrial Structure and Function
Epithelial monolayers were fixed on filter supports and processed for transmission EM.15,19 Epithelial mitochondrial activity was assessed by the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide salt] assay after a 24-hour exposure to DNP (0.1 mmol/L).25
Barrier Function
Transepithelial resistance (TER in · cm2; indicates barrier to passive ion flux) across filter-grown monolayers was monitored using a voltmeter and matched electrodes (Millicell-ERS; Millipore, Bedford, MA) and expressed as the percentage of pretreatment TER.23
HRP flux assays were conducted as described.26
Twenty-four hours after DNP ± E. coli HB101 treatment, HRP (10 µmol/L) was added to the apical side of filter-grown T84 cell monolayers. Two hours later samples were retrieved from the basal compartment of the culture well and HRP amounts determined by enzymatic assay and presented as percent recovery of the amount added.
Internalization of Bacteria and Bacterial Translocation
Semiconfluent monolayers of T84 cells were grown in six-well plates and inoculated with E. coli HB101 (106 cfu/ml) ± DNP and incubated for 24 hours at 37°C. A sample of bacterial culture was collected and the number of bacteria determined using the Miles and Misra method. Epithelia were washed extensively and treated with gentamicin (300 µg/ml, Sigma Chemical Co.) for 1 hour, at which point the epithelia were rinsed with sterile PBS (three times), lysed with 1.0 ml of cold 1% Triton X-100/PBS (10 minutes at 4°C) and plated onto LB agar. The number of internalized, viable bacteria was determined and presented as a percentage of the number of extracellular bacteria after the 24-hour growth period.
For translocation assays, T84 cells were grown to confluence on 3-µm pore-size filters, transferred to antibiotic-free medium, and inoculated apically with E. coli HB101 ± DNP. Aliquots were collected from the basolateral compartment 16 hours later and the number of bacteria determined.
F-Actin and 
-Actinin Visualization
Epithelial preparations were rinsed in PBS, fixed with 4oC methanol or formalin for 10 to 20 minutes, and incubated with mouse anti-human -actinin antibodies (1:100 dilution, Sigma Chemical Co.) for 1 hour at 37°C. Epithelia were rinsed in cold PBS and incubated with fluorescein isothiocyanate-labeled donkey anti-mouse IgM µ-chain-specific antibodies (1 hour at 37°C, 1:100 dilution; Jackson ImmunoResearch Lab Inc., West Grove, PA).27
After three PBS rinses, the cells were stained with propidium iodide to identify the nucleus. Additional monolayers were treated with Texas Red-conjugated phalloidin (0.1 µmol/L; Molecular Probes, Eugene, OR) to identify filamentous (F) actin.28
Coded preparations were observed on a Zeiss 510 confocal scanning laser microscope.
Interleukin (IL)-8 Enzyme-Linked Immunosorbent Assay
Epithelial cells were grown to 80% confluence, exposed to E. coli HB101 ± DNP for 24 hours and 1) RNA extracted and reverse transcriptase-polymerase chain reaction performed for IL-8 followed by densitometric analysis of the electrophoretic gel as previous described29
and 2) culture medium samples collected 24 hours later for IL-8 determination by commercial enzyme-linked immunosorbent assay (R&D Systems, Minneapolis, MN). Epithelia treated with tumor necrosis factor (TNF)- (10 ng/ml) or exposed to EPEC (106 cfu) for 24 hours served as positive controls for induction of IL-8. The assay detection limit was 16 pg/ml. Pharmacological inhibitors were added, at the doses indicated, 30 minutes before E. coli HB101 ± DNP treatment.
Electrophoretic Mobility Shift Assay
Epithelial nuclear protein extracts were obtained and electrophoretic mobility shift assay conducted using a published protocol23
with end-labeled double-stranded oligonucleotides bearing the AP-1 consensus binding sequence: 5'-CGC TTG ATG ACT CAG CCG GAA-3' (Santa Cruz Biotechnology, Santa Cruz, CA). Specificity controls consisted of non-32P-labeled double-stranded DNA oligonucleotide as a cold competitor and supershifts with a pan-anti-Fos antibody (K-25, Santa Cruz Biotechnology). Nuclear extracts from TNF- (10 ng/ml, R&D Systems)-treated epithelia served as positive controls.
Statistical Analyses
Data are presented as mean ± SEM and n values are the number of individual epithelial preparations. Data were analyzed with Student’s t-test or a one-way analysis of variance followed by posthoc comparisons with the Neuman-Keuls test. A statistically significant difference was accepted at P < 0.05.
|
Results |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
. Morphometric analysis confirmed a significant increase in average mitochondrial area (0.57 ± 0.11 µm2) in tissues from patients with Crohn’s disease compared to resections from patients with cancer (0.19 ± 0.06 µm2; P < 0.05; n = 60 mitochondria from three patient samples). These findings support previous literature indicative of altered energy metabolism in gut tissues from patients with IBD,14
and provided the impetus to proceed to complementary animal and in vitro studies.
|
To mimic the conditions observed in human tissue, DNP was used to uncouple oxidative phosphorylation.17
Instillation of DNP into the distal ileum of rats resulted in damaged epithelial mitochondria (mitochondria size, PBS = 0.51 ± 0.02 µm2 versus DNP = 0.79 ± 0.05 µm2; P < 0.05; n = 60 mitochondria from four rats) and an apparent increase in bacteria attached to, and inside, the enterocytes of treated intestine. These changes were most apparent at 6 hours after DNP treatment (Figure 2; A to C)
. The increased occurrence of bacteria in tissues from DNP-treated rats was confirmed by culturing tissue homogenates that had been treated with antibiotics to kill attached bacteria: control = 7.5 x 104 versus DNP-treated = 6.8 x 105 cfu/g tissue (average of two rats).
|
. Histological assessment of ileal sections from the DNP-treated rats revealed increased numbers of mononuclear and polymorphonuclear immune cells in the mucosa by 6 hours after treatment that remained elevated until 24 hours after treatment (Figure 2F)
. There were no differences between the magnitude of the increase in immune cells at 6 and 24 hours after DNP. This suggests that either the maximum response has occurred by 6 hours, or that there is increased immune cell traffic to the gut in the 6- to 24-hour period that is balanced by exit from the tissue perhaps as cells move to the local draining lymph nodes. Commensal E. coli Strains in the Presence of DNP Disrupt Epithelial Barrier Function
A cell culture model was used to delineate the mechanism of the altered epithelial function after exposure to DNP + nonpathogenic E. coli. Initial experiments revealed that low-dose DNP (0.1 mmol/L) did not affect the growth of E. coli HB101 (n = 2) (1.0 mmol/L blocked bacteria growth), but did result in swollen, irregular epithelial mitochondria and reduced mitochondrial activity by 30 to 40% as indicated by the MTT assay (n = 3); these effects of DNP have been reported previously.17
Exposure of polarized T84 epithelial cell monolayers to DNP (0.1 mmol/L) or E. coli HB101 (106 cfu) alone did not affect TER (a marker of paracellular permeability). In contrast, DNP + E. coli HB101 treatment resulted in significant increases in epithelial permeability that were apparent by 10 hours after infection and maximal at 24 hours after infection (end of experiment) (Figure 3, A and B)
. A 24-hour exposure to DNP + E. coli HB101 also resulted in increased transepithelial flux of the 44-kd protein, HRP that traverses the epithelium via transcellular and paracellular (albeit to a less extent) routes (Figure 3C)
.
|
. Also, a 24-hour exposure to E. coli C25 alone increased the transepithelial flux of HRP (control = 1.1 ± 0.5 x 10-3 versus C25 = 11.2 ± 4.5 x 10-3% of apical HRP dose) and this was increased approximately threefold by co-treatment with DNP (30.5 ± 6.8 x 10-3% of apical HRP; n = 6; *, P < 0.05 compared to E. coli C25 only). These data are consistent with E. coli C25 designation as a putative low-grade pathogen20
and show that metabolically stressed epithelia are more sensitive to this organism. DNP may have elicited effects by affecting the bacteria, the enterocytes, or both. Exposure of T84 cells to 1) DNP-treated E. coli HB101, 2) heat-killed E. coli HB101 + DNP, 3) a 0.22-µm culture medium filtrate from naïve bacterial cultures, 4) medium from DNP-treated bacterial cultures, or 5) medium from E. coli HB101 24-hour cultures spiked with DNP (0.1 mmol/L) each failed to significantly affect TER (n = 6 monolayers/condition; data not shown). Thus, the increase in epithelial permeability evoked by DNP + E. coli HB101 required the presence of viable organisms, was not dependent on a bacteria-derived product, and was because of the impact of DNP on the epithelium.
Pharmacological studies have implicated the intracellular signaling molecules, ERK 1/2 MAPK, PI-3K, and MLCK in the control of epithelial paracellular permeability.23,30,31
Indeed, MLCK activation is important in the drop in TER that occurs after EPEC infection.19,31
Use of U0126, LY294002, and ML-7 to inhibit the activity of ERK 1/2 MAPK, PI-3K, and MLCK, respectively, failed to ameliorate the drop in TER evoked by DNP + E. coli HB101 (Figure 3D)
. We have used these drugs to successfully block cytokine signaling in T84 and HT-29 epithelia21-23
and ML-7 partially prevented the reduced TER caused by exposure to EPEC (Figure 3D)
.
However, there were discernable effects on the enterocytic cytoskeleton that were reminiscent of infection with EPEC or parasitic protozoa19,32
—DNP + E. coli HB101 treatment resulted in dissociation of F-actin from the perijunctional actinomyosin ring, and focal condensations of F-actin and the actin-associated protein, -actinin (Figure 3E)
.
Like DNP, the nonsteroid anti-inflammatory drug indomethacin can interfere with oxidative phosphorylation. Indomethacin (10 µmol/L) alone did not alter T84 monolayer TER nor did it affect E. coli HB101 growth. Figure 4
shows that monolayers exposed for 24 hours to the combination of indomethacin + E. coli HB101 displayed a significant drop in TER (n = 11).
|
Transmission EM photomicrographs revealed increased numbers of bacteria inside T84 cells exposed to DNP + E. coli HB101 for 24 hours, with occasional bacteria being noted in the paracellular space (Figure 5, a and b)
. Bacteria were not observed in sections of control monolayers, which could be because of sampling and the small area examined. However, a modified bacterial invasion assay confirmed the presence of 10-fold increase in intracellular bacteria compared to E. coli-only treated cells (Figure 5c)
. Coupling DNP + E. coli HB101 also resulted in significant bacteria translocation across the filter-grown epithelial monolayers: bacteria were found in the basal compartment of every (n = 18) monolayer treated 16 hours previously with DNP + E. coli HB101, whereas bacterial translocation was not apparent during the same time frame in T84 monolayers treated with E. coli HB101 only (n = 18).
|
Entry of bacteria into the mucosa represents a serious threat to the host that could result in sepsis and multiorgan failure. The DNP + E. coli HB101-induced drop in TER and concomitant increases in bacterial translocation could be accompanied by induction of an alarm response from the enterocyte to mobilize an anti-bacterial response. Reverse transcriptase-polymerase chain reaction analysis revealed a small increase in IL-8 mRNA in DNP + E. coli HB101-treated epithelia (Figure 6, A and B)
and this was translated into increased IL-8 protein: T84 cells displayed a 29 ± 7% (P < 0.05, n = 8) increase in IL-8 protein 24 hours after co-treatment, whereas DNP + E. coli HB101 evoked approximately twofold increase in IL-8 production in the human HT-29 colonic epithelial cell line (HB101 only = 2.21 ± 0.12 versus DNP + HB101 = 4.67 ± 0.36 ng/ml, P < 0.05; n = 5). The increase in IL-8 secretion from HT-29 cells was prevented by use of pharmacological inhibitors of the ERK and p38 MAPK pathways, and NF-B signaling (Figure 6C)
. It should be noted that EPEC-infected HT-29 cells produced more IL-8 that those treated DNP + HB101 (P = 0.04) and, consistent with earlier findings,29
TNF- exposure led to a massive increase in IL-8 (61.5 ± 7.3 ng/ml; n = 5; P < 0.001 compared to control and DNP + HB101).
|
, but not to either agent alone. |
Discussion |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
.
|
Recently we reported that exposure of rats to mild chronic stress resulted in disrupted epithelial mitochondrial structure, increased bacterial attachment to the epithelium, and a low-grade ileal and colonic mucosal inflammation.16 The abnormalities were a consequence of the stress—supporting the hypothesis of stress-induced gut dysfunction.9 However, it remained unclear if the mitochondrial dysfunction resulted in bacterial attachment and if the inflammatory infiltrate was a consequence of epithelial cell activation or vice versa. Thus experiments were initiated with DNP, which by virtue of its ability to uncouple oxidative phosphorylation would be expected to elicit any gut effects by affecting energy metabolism/mitochondria activity.
Direct instillation of DNP into the lumen of rat ileum caused the predicted perturbation of epithelial mitochondrial structure, and resulted in increased epithelial permeability, bacterial penetration, and an immune cell infiltrate: gut events reminiscent of those observed in the stress model.16 However, the inflammatory infiltrate was subtle (ie, approximately twofold increase) and was quantifiably similar at 6 and 24 hours after treatment, suggesting either an equilibrium had been reached between cell influx and exit or that the effect of this acute DNP treatment peaked at 6 hours after treatment. The lack of obvious tissue damage and sustained immune cell accumulation may indicate a generalized gut response to low-grade insults (eg, limited periods of ischemia); moreover, it suggests that the DNP exposure has primed the intestine to respond more aggressively to otherwise nonnoxious stimuli. Together, the data strongly support the concept that the epithelial abnormality was the catalyst for the enteric changes. However, the possibility that the effects of DNP were mediated by dendritic cells or intraepithelial lymphocytes that can be exposed to the luminal contents, or other mucosal cells could not be unequivocally dismissed.42,43 A cell culture approach was adopted to address this issue.
Low-dose DNP added to epithelial monolayers resulted in disrupted mitochondrial structure and function but did not affect TER, suggesting negligible cytotoxic effects of DNP at this dose and the importance of maintaining an intact epithelial barrier. Consistent with previous findings, E. coli HB101 had no, or negligible, effects on T84 TER.19 Strikingly, DNP + E. coli HB101 treatment resulted in dramatic changes in epithelial paracellular and transcellular permeability as gauged by the transepithelial movement of ions (ie, TER) and the larger, potentially antigenic protein HRP, respectively. The findings were reproduced with two human colonic epithelial cell lines and two E. coli strains: the nonpathogenic HB101 control stain and C25, a clinical isolate and potential low-grade pathogen. Thus, the metabolically stressed epithelia have become sensitive or hyperresponsive to both nonnoxious and mild pathogens. It is important, and clinically relevant given the association between NSAID use and relapse in IBD, to highlight that the combination of indomethacin and E. coli HB101 also evoked a significant drop in TER. However, because indomethacin inhibits both arachidonic acid metabolism and affects mitochondria we focused the subsequent mechanistic studies on DNP, which selectively interferes with mitochondrial function.
Analysis of a variety of control experiments supports the view that the increased epithelial permeability requires contact with live bacteria and is not because of the release of a soluble product from E. coli. Also, the possibility that the DNP was converting the nonpathogenic E. coli HB101 into a pathogen was dismissed by experiments with DNP-treated E. coli HB101. Furthermore, use of pharmacological inhibitors that block intracellular signals known to be involved in control of epithelial tight junctions, and hence paracellular permeability (ie, ERK MAPK, PI-3K, and MLCK), all failed to prevent the barrier defect evoked by DNP + E. coli HB101. The lack of involvement of MLCK is particularly intriguing because this enzyme has been implicated in EPEC- and EHEC-induced increases in epithelial permeability.22,31
Moreover, although focal modifications in the distribution of F-actin and -actinin were associated with DNP + E. coli HB101 treatment, and these were somewhat reminiscent of the enterocytic cytoskeletal response to EPEC infection,19
attaching-effacing lesions typical of EPEC infection44
were not observed. Thus, although the data indicate that epithelia under metabolic stress can perceive nonpathogenic commensal bacteria as threatening, this response is distinct from that elicited by known bacterial pathogens such as EPEC and EHEC. Moreover, should these findings extrapolate to human disease then precise definition of the mechanisms responsible for the DNP + E. coli HB101-induced disruption of epithelial barrier function has the potential to provide insight into how commensal bacteria may evoke IBD or stress-induced relapses in IBD.
EM revealed increased numbers of bacteria within the enterocyte and in the paracellular spaces and this was confirmed by invasion assays that revealed an 10-fold increase in intracellular bacteria in DNP + E. coli HB101-treated epithelia compared to E. coli HB101-only treatedcells. The increase in intracellular bacteria was accompanied by a marked increase in bacterial translocation across the filter-grown polarized monolayers. This was an unexpected finding because E. coli HB101 is noninvasive and was, to us, particularly intriguing in light of reports describing increases in adherent bacteria on tissue resections from patients with IBD.45,46
Further use of this model to explore the mechanism of the enhanced bacterial translocation may present means to block similar in vivo events.
Reduced barrier function in vivo and bacterial penetration across the epithelium would be expected to elicit an immune response, which could either effectively neutralize the pathogen/antigen or if inappropriately controlled result in inflammatory disease. In this context we found that exposure to DNP + E. coli HB101 evoked a significant increase in epithelial IL-8 production, an event not observed with DNP or E. coli HB101 alone. This up-regulation of IL-8 synthesis by model epithelia in vitro complements the in vivo observation of an inflammatory cell infiltrate in the DNP-treated rat ileum. However, this enhanced IL-8 production was significantly less than that evoked by TNF- or EPEC exposure, which is again consistent with the postulate that metabolic stress in the face of a normally nonnoxious commensal flora triggers events that could predispose an individual to more vigorous subsequent immune responses.
The ERK and p38 MAPKs, and NF-B are important controls of IL-8 production and all have been implicated in the regulation of enteric epithelial IL-8 synthesis.21
In accordance with this the DNP + E. coli HB101 induced IL-8 was abrogated by pharmacological inhibitors of all three signal transduction pathways. Additionally, AP-1 activation (ie, DNA binding activity), a downstream signal from ERK MAPK that is involved in the regulation of IL-8 production,33
was only increased in DNP + E. coli HB101-treated epithelial. Thus, the findings that the epithelial IL-8 synthesis was ERK-, p38-, and NF-B-dependent are in agreement with the current understanding of the control of IL-8 production and this contrasts with the DNP + E. coli HB101-induced perturbation of epithelial barrier function, the mechanism of which remains to be elucidated. Finally, and perhaps most importantly, the data indicate that the stressed (ie, DNP-treated) enterocyte responds differently to nonpathogenic bacteria, mobilizing a panel of signals and subsequent gene activation events that may cause inflammation and supports a central role for the epithelium in the modulation of mucosal immunity.
In conclusion, based on initial observations with human tissues this study presents data from in vivo and in vitro investigations as proof-of-principal evidence in support of our hypothesis (Figure 7)
, in which perturbations of epithelial cell energy metabolism results in normally innocuous bacteria being perceived as a threat that could lead to inflammatory disease should the altered epithelial response (eg, increased permeability, bacterial translocation, chemokine synthesis) be prolonged.
|
Footnotes |
|---|
Supported by a group grant from the Crohn’s and Colitis Foundation of Canada.
P.M.S. is the recipient of a Canada Research Chair in Gastrointestinal Disease.
Accepted for publication November 19, 2003.
|
References |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
and tumour necrosis factor-. Inhibition of increased permeability, but not diminished secretory responses by transforming growth factor ß2. J Immunol 1997, 159:2382-2390B-independent pathway. FASEB J 2003, 17:1319-1321This article has been cited by other articles:
 |
|
 |
|
  K. Lewis, J. Caldwell, V. Phan, D. Prescott, A. Nazli, A. Wang, J. D. Soderholm, M. H. Perdue, P. M. Sherman, and D. M. McKay Decreased epithelial barrier function evoked by exposure to metabolic stress and nonpathogenic E. coli is enhanced by TNF-{alpha} Am J Physiol Gastrointest Liver Physiol, March 1, 2008; 294(3): G669 - G678. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Boudry, J. Jury, P. C. Yang, and M. H. Perdue Chronic psychological stress alters epithelial cell turn-over in rat ileum Am J Physiol Gastrointest Liver Physiol, May 1, 2007; 292(5): G1228 - G1232. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Reardon and D. M. McKay TGF-beta Suppresses IFN-{gamma}-STAT1-Dependent Gene Transcription by Enhancing STAT1-PIAS1 Interactions in Epithelia but Not Monocytes/Macrophages J. Immunol., April 1, 2007; 178(7): 4284 - 4295. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. McKay, J. L. Watson, A. Wang, J. Caldwell, D. Prescott, P. M. J. Ceponis, V. Di Leo, and J. Lu Phosphatidylinositol 3'-Kinase Is a Critical Mediator of Interferon-{gamma}-Induced Increases in Enteric Epithelial Permeability J. Pharmacol. Exp. Ther., March 1, 2007; 320(3): 1013 - 1022. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Daniel, S. Poiret, D. Goudercourt, V. Dennin, G. Leyer, and B. Pot Selecting Lactic Acid Bacteria for Their Safety and Functionality by Use of a Mouse Colitis Model Appl. Envir. Microbiol., September 1, 2006; 72(9): 5799 - 5805. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Johnson and M. Fleshner Releasing signals, secretory pathways, and immune function of endogenous extracellular heat shock protein 72 J. Leukoc. Biol., March 1, 2006; 79(3): 425 - 434. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Nazli, A. Wang, O. Steen, D. Prescott, J. Lu, M. H. Perdue, J. D. Soderholm, P. M. Sherman, and D. M. McKay Enterocyte Cytoskeleton Changes Are Crucial for Enhanced Translocation of Nonpathogenic Escherichia coli across Metabolically Stressed Gut Epithelia Infect. Immun., January 1, 2006; 74(1): 192 - 201. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. Howe, C. Reardon, A. Wang, A. Nazli, and D. M. McKay Transforming Growth Factor-{beta} Regulation of Epithelial Tight Junction Proteins Enhances Barrier Function and Blocks Enterohemorrhagic Escherichia coli O157:H7-Induced Increased Permeability Am. J. Pathol., December 1, 2005; 167(6): 1587 - 1597. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. C. H. Yu, A. N. Flynn, J. R. Turner, and A. G. Buret SGLT-1-mediated glucose uptake protects intestinal epithelial cells against LPS-induced apoptosis and barrier defects: a novel cellular rescue mechanism? FASEB J, November 1, 2005; 19(13): 1822 - 1835. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Kohler, O. Zaborina, L. Wu, Y. Wang, C. Bethel, Y. Chen, J. Shapiro, J. R. Turner, and J. C. Alverdy Components of intestinal epithelial hypoxia activate the virulence circuitry of Pseudomonas Am J Physiol Gastrointest Liver Physiol, May 1, 2005; 288(5): G1048 - G1054. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E Isolauri, S Rautava, and M Kalliomaki Food allergy in irritable bowel syndrome: new facts and old fallacies Gut, October 1, 2004; 53(10): 1391 - 1393. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
